Tim Lancaster of Indigo BioAutomation and Mark Perkins of The Binding Site join us to share how they’re bringing artificial intelligence and mass spectrometry together to make significant improvements in the world of multiple myeloma.
Mark’s team saw a massive opportunity to improve multiple myeloma diagnostics, but they knew they needed a software partner. Tim’s team at Indigo Bioautomation proved to be the perfect fit. Mark and Tim share about their powerful partnership and their journey from turning an idea to a tool that will change patients’ lives.
Tim’s career has focused on providing leading edge software to the life science and medical industry. As Executive Vice President of Product Development, Tim is responsible for the design, development, delivery, and production operation of Indigo’s software products. Tim has hands-on experience in the construction of complex software using a wide variety of technologies and processes. Tim brings a constant drive to improve and a history of identifying and leading tactical and strategic changes to help the whole team succeed.
Mark has a PhD in pharmaceutical studies and spent the first 10 years of his career in the pharmaceutical industry before he moved into diagnostics. In his current role as the Global Head of Mass Spectrometry – Business Development at The Binding Site, Mark leads commercial and research development for a new product line. He loves seeing products come to life and go to market.
With his diverse background and expertise, Zac brings a unique perspective to discussions around innovation, leadership, and the ever-evolving tech landscape. His ability to bridge technical and business domains makes him a valuable voice in the industry.
Zac's LinkedIn
In our Behind the Product podcast, we put the spotlight on the practices that guide decision makers in solving some of society's toughest challenges.
Looking to advance your career? Explore what it's like to work on awesome things with curious, confident people.
